Exact Sciences
Exact Sciences offers a comprehensive suite of cancer detection and treatment guidance tests, including the well-known Cologuard® for colorectal cancer screening, and collaborates with leading institutions like Mayo Clinic and Johns Hopkins University.
Services
Exact Sciences offers a comprehensive suite of tests focused on hereditary cancer testing, earlier cancer detection, treatment guidance, and therapy selection. These services aim to provide accurate and reliable testing to inform better healthcare decisions.
Products
Exact Sciences has developed several tests including Cologuard®, a stool DNA-based colorectal cancer screening test, OncoExTra™, a test for advanced solid tumors, Oncoguard® Liver, a blood test for early-stage hepatocellular carcinoma detection, Oncotype DX®, a series of genomic tests for breast and colon cancer, Riskguard™, a hereditary cancer test, LBgard® Blood Tubes for preserving cell-free DNA, Cancerguard™, a multi-cancer early detection test, and a next-generation Cologuard test.
Collaborations
Exact Sciences collaborates with leading institutions such as Mayo Clinic on cancer screening and biomarker identification, Johns Hopkins University on multi-cancer screening technology, and TGen, an affiliate of City of Hope, on minimal residual disease testing. These collaborations aim to enhance the accuracy and effectiveness of cancer detection and treatment.
Patient Support Programs
Exact Sciences provides various support programs including a Patient Engagement Program to ensure adherence to surveillance testing and a Patient Assistance Program to help patients receive tests at no cost. The company is committed to increasing access to cancer screening for underserved populations and engages in community health initiatives.
Research and Innovations
Exact Sciences conducts clinical studies to validate the performance of their tests and offers grants for research in colorectal cancer, multi-cancer early detection, and other areas. They've developed innovative solutions like a Breast Radiation Score test to evaluate radiation therapy benefits after breast-conserving surgery and a blood-based screening method for colorectal cancer.